Anorexia
Anorexia
Explore linked clinical trials. Standard reference: MESH:M000127828 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer | Anorexia, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Phase 2 / Phase 3 | 2026-10-06 | NCT03637816 | |
| Effects of Synbiotic Supplementation on Gastrointestinal Symptoms, Appetite, and Nutritional Recovery in Patients After Autologous Bone Marrow Transplant | Anorexia, Dysbiosis, Hemic and Lymphatic Diseases, Neoplasms by Site, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm, nutritional deficiency disease, nutritional disorder | Not yet recruiting | Not applicable | 2026-10-01 | NCT07845669 | |
| A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss | Anorexia, Body Weight, Body Weight Changes, Cachexia, Fatigue, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Thoracic Neoplasms, Weight Loss, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07663630 | |
| A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue | Anorexia, Body Weight, Body Weight Changes, Cachexia, Digestive System Diseases, Digestive System Neoplasms, Fatigue, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Weight Loss, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-09-25 | NCT06989437 | |
| Visugromab in Cachexia International Trial | Anorexia, Body Weight, Body Weight Changes, Cachexia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Weight Loss, neoplasm | Recruiting | Phase 2 / Phase 3 | 2026-09-22 | NCT07112196 | |
| Study on the Prevention of Weight Loss Through Physical Activity Among Nursing Home Residents | Anorexia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive | Not yet recruiting | Not applicable | 2026-09-21 | NCT07831733 | |
| Prophylactic Nanocrystalline Megestrol Acetate Versus Placebo for Chemoradiotherapy-Related Anorexia in Nasopharyngeal Carcinoma | Anorexia, Body Weight, Body Weight Changes, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pathological Conditions, Signs and Symptoms, Pharyngeal Diseases, Signs and Symptoms, Signs and Symptoms, Digestive, Stomatognathic Diseases, Weight Loss, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 3 | 2026-09-01 | NCT07796789 | |
| An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia Nervosa | Anorexia, Feeding and Eating Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, anorexia nervosa, psychiatric disorder | Not yet recruiting | Phase 2 | 2026-08-03 | NCT06518941 | |
| Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients | Anorexia, Hemic and Lymphatic Diseases, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, hematologic disorder, hematopoietic and lymphoid cell neoplasm, hematopoietic and lymphoid system neoplasm, neoplasm | Active, not recruiting | Phase 3 | 2026-07-30 | NCT04939090 | |
| Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer | Anorexia, Body Weight, Body Weight Changes, Cachexia, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Weight Loss, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, esophageal disorder, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2026-07-16 | NCT05705492 | |
| Ruxolitinib for Cancer Cachexia | Anorexia, Atrophy, Body Weight, Body Weight Changes, Cachexia, Neoplasms by Site, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Thoracic Neoplasms, Weight Loss, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, muscular atrophy, neoplasm, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Early phase 1 | 2026-07-07 | NCT04906746 | |
| Impact of Auditory Stimulation in Eating Pleasure (EDERE 2021) | Anorexia, Ear Diseases, Frailty, Hearing Loss, Sensorineural, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, Signs and Symptoms, Digestive, hearing disorder, hearing loss disorder, nervous system disorder, nutritional deficiency disease, nutritional disorder, otorhinolaryngologic disease, presbycusis | Recruiting | Not stated | 2026-06-29 | NCT04923087 | |
| Ketamine Effects on Learning In Eating Disorders | Anorexia, Feeding and Eating Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, anorexia nervosa, anxiety disorder, depressive disorder, psychiatric disorder | Enrolling by invitation | Phase 2 | 2026-06-12 | NCT06736769 | |
| Effects of Mirtazapine on Appetite in Advanced Cancer Patients | Anorexia, Body Weight, Body Weight Changes, Dyssomnias, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Sleep Disorders, Intrinsic, Weight Loss, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder | Active, not recruiting | Phase 2 | 2026-06-12 | NCT00488072 | |
| Dexamethasone for Symptom Burden in Advanced Cancer Patients | Anorexia, Fatigue, Nausea, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive | Active, not recruiting | Phase 2 | 2026-06-08 | NCT00489307 | |
| Fecal Microbiota Transplant for Anorexia Nervosa | Anorexia, Feeding and Eating Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, anorexia nervosa, psychiatric disorder | Not yet recruiting | Not applicable | 2026-05-27 | NCT06593366 | |
| Pediatric Prolonged-Release Melatonin for Sleep Disturbances in Children and Adolescents With Anorexia Nervosa (MELSom-ANOREXIA) | Anorexia, Feeding and Eating Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, anorexia nervosa, psychiatric disorder | Not yet recruiting | Phase 3 | 2026-05-08 | NCT07576764 | |
| Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy | Anorexia, Body Weight, Body Weight Changes, Cachexia, Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Weight Loss, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm, nutritional deficiency disease, nutritional disorder | Not yet recruiting | Phase 2 | 2026-05-04 | NCT07565415 | |
| Identifying Networks Underlying Compulsivity in Anorexia Nervosa for Targeting With Neuromodulation | Anorexia, Feeding and Eating Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, anorexia nervosa, anxiety disorder, obsessive-compulsive disorder, psychiatric disorder | Active, not recruiting | Not applicable | 2026-05-01 | NCT06138782 | |
| Body Composition in Adolescents With Anorexia Nervosa | Anorexia, Feeding and Eating Disorders, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Spasm, anorexia nervosa, nervous system disorder, psychiatric disorder | Recruiting | Not stated | 2026-03-30 | NCT06800742 | |
| AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT) | Anorexia, Chemically-Induced Disorders, Drug Abuse, Neurobehavioral Manifestations, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, agnosia, nervous system disorder, perceptual disorders, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 1 | 2026-03-20 | NCT04859296 | |
| Biolizin for Improving Functional Poor Appetite in Children Aged 6 to 36 Months (CTBE2502) | Anorexia, Appetite Disorders, Feeding and Eating Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, psychiatric disorder, rumination disorder | Recruiting | Not applicable | 2026-01-30 | NCT07153549 | |
| The Effect of a Protective Oral Care Protocol Using Peppermint Oil Mouthwash | Anorexia, Hemic and Lymphatic Diseases, Nausea, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Not yet recruiting | Not applicable | 2025-09-17 | NCT07179094 | |
| A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms | Abdominal Pain, Anorexia, Deglutition Disorders, Digestive System Diseases, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, constipation disorder, digestive system disorder, dyskinesia of esophagus, dyspepsia, esophageal disorder, gastroesophageal reflux disease | Recruiting | Not stated | 2025-05-14 | NCT06755671 | |
| Circulating and Molecular Markers Involved in the Processes of Cachexia, Anorexia and Sarcopenia in Patients With NSCLC | Anorexia, Atrophy, Body Weight, Body Weight Changes, Cachexia, Neoplasms by Site, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, Signs and Symptoms, Digestive, Thinness, Thoracic Neoplasms, Weight Loss, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, muscular atrophy, neoplasm, nervous system disorder, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not stated | 2025-02-05 | NCT06808113 |